PER 1.18% 8.4¢ percheron therapeutics limited

Ann: Phase II DMD trial database lock and final results on track, page-95

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,049 Posts.
    lightbulb Created with Sketch. 516
    Still a couple of weeks to go! -

    Quarterly Update & Appendix 4C • DMD Phase II trial final results due in the coming weeks • US-based Consultant Medical Director appointed to accelerate development activities • Positive results in DMD unlock the broader value creation potential of ATL1102
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $86.05M
Open High Low Value Volume
8.5¢ 8.6¢ 8.3¢ $67.87K 801.4K

Buyers (Bids)

No. Vol. Price($)
3 204125 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4029 2
View Market Depth
Last trade - 14.19pm 13/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.